Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/05/019386
CTRI/2019/05/019386
Suspended
未知

An open label crossover study to estimate Glycemic index of Murchit Atta as compare to Regular Atta in a patients with Type 2 Diabetes mellitus

Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital
Status
Suspended
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients of either sex in the age group between 18 to 50 years (Both Inclusive)
  • •2\. Willing to provide written informed consent
  • •3\. Patients diagnosed to be suffering from Type 2 diabetes mellitus taking oral hypoglycemic drugs and with blood sugar stabilized within normal range(Fasting sugar level \< 110 mg/dl and Postprandial sugar level \< 140 mg/dl )

Exclusion Criteria

  • •1\.Patients of either sex having age below 18 and above 50
  • •2\. Not willing to provide written inform consent
  • •3\. Patients diagnosed as Type 1 diabetes mellitus
  • •4\. Patients with past 30 days history
  • •A) Any major illness that required hospitalization
  • •B) acute exacerbation of any ongoing chronic medical illness e.g. Congestive cardiac failure Hepatitis Hypotensive episodes HIV etc Medications requiring change of doses for treatment of the chronic illness
  • •5\. Patients suffering from severe cardiac renal liver or any other organ impairment.
  • •6\. History of seizures epilepsy or any neurological disorders
  • •7\. Recent history of dehydration from diarrhoea vomiting or any other reason within a period of 24 hours prior to enrolment in the study
  • •8\. Patient with any history of food allergy or any ingredient of investigational Murchit atta

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Estimate glycemic index of Murchit attaHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2019/04/018362Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital
Completed
Not Applicable
Open-label cross-over study to evaluate the amount of residual inhaled corticosteroid (hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP) and fluticasone propionate dry powder inhaler (FP-DPI)) in the mouths of elderly asthmatic patients after each inhalatioAsthma
JPRN-UMIN000001323JA Gifu Kouseiren Tohno-Kousei Hospital22
Completed
Not Applicable
An open label, crossover study to investigate the safety and tolerability of Sifrol® (pramipexole) (Boehringer Ingelheim) prolonged release tablets in order to establish the maximum tolerable dose and to assess bioequivalence of Pramipexole prolonged release tablets (Synthon B.V.) compared to Sifrol® prolonged release tablets (Boehringer Ingelheim) in healthy subjects in steady-state conditionsparkinson's disease10042258
NL-OMON36833Synthon B.V52
Completed
Not Applicable
A study for measurement of Glycemic Index (GI) of two kinds of foods in adult males and females
JPRN-UMIN000037071TTC Co., Ltd.12
Recruiting
Not Applicable
A single-center open-label crossover study of the clinical utility and safety of the BV-UFC system of the DCS-200Si dialysis monitorPatients undergoing hemodialysishemodialysisD006435
JPRN-jRCT1062230034Hamada Shintaro20